Rachel Rabinovitch, MD

Professor, Radiation Oncology


FacultyPhoto
Medical School
  • MD, Albert Einstein College of Medicine of Yeshiva University (1989)
Undergraduate School
  • BS, University of California–Los Angeles (CA) (1985)
Internship
  • Staten Island University Hospital Program (1990)
Residency
  • Memorial Sloan-Kettering Cancer Center Program, Chief Resident, Radiation Oncology (1993)
Languages
English, Hebrew
Department
Radiation Oncology

Professional Titles

  • Professor

Recognitions

  • Top Doctor, 5280 Magazine (2010)
  • Top Doctor, 5280 Magazine (2009)
  • Top Doctor, 5280 Magazine (2008)
  • Top Doctor, 5280 Magazine (2006)
  • Top Doctor, 5280 Magazine (2005)
  • Clinical Poster Recognition Award - “Improved Disease Specific and Overall Survival in Patients with Early Stage Low Grade Follicular Lymphoma Treated with External Beam Radiation: A Surveillance, Epidemiology, and End Results Analysis”, ASTRO (2008)
  • Top Doctor, US News and World Reports (2011)
  • Top Doctor, 5280 Magazine (2017)
  • Top Doctor, 5280 Magazine (2016)

Research Interests

My research focus in breast cancer has related to accelerated partial breast irradiation (I am a co-PI for NSABP B39/RTOG 0413), DCIS (I am co-PI for NSABP B43), and post-mastectomy radiotherapy. I have published extensively in breast cancer and lymphoma radiotherapy. I am a member of the NCI's Breast Oncology Local Disease (BOLD) task force. I serve as co-Chair of NRG Oncology's Quality Control Committee and and am a member of the Breast Working Group Committee and the International Lymphoma Radiation Oncology Group (ILROG).

Publications

  • Improved survival in patients with early stage low-grade follicular lymphoma treated with radiation: a Surveillance, Epidemiology, and End Results database analysis. Pugh TJ, Ballonoff A, Newman F, Rabinovitch R. Cancer. 2010 Aug 15;116(16):3843-51
  • Respiratory organ motion and dosimetric impact on breast and nodal irradiation. Qi XS, White J, Rabinovitch R, Merrell K, Sood A, Bauer A, Wilson JF, Miften M, Li XA. Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):609-17. Epub 2010 May 14
  • Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation" (Int J Radiat Oncol Biol Phys 2010;76:71-78) and "Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation" Int J Radiat Oncol Biol Phys 2009;75:1290-1296). Wolmark N, Curran WJ, Vicini F, White J, Costantino JP, Arthur D, Kuske R, Rabinovitch R, Julian TB, Parda DS. Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):317; author reply 318
  • American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapy. Erickson BA, Demanes DJ, Ibbott GS, Hayes JK, Hsu IC, Morris DE, Rabinovitch RA, Tward JD, Rosenthal SA. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):641-9. Epub 2010 Nov 23
  • ACR Appropriateness Criteria® on nonpalpable mammographic findings (excluding calcifications). Newell MS, Birdwell RL, D'Orsi CJ, Bassett LW, Mahoney MC, Bailey L, Berg WA, Harvey JA, Herman CR, Kaplan SS, Liberman L, Mendelson EB, Parikh JR, Rabinovitch R, Rosen EL, Sutherland ML. J Am Coll Radiol. 2010 Dec;7(12):920-30
  • Phase I trial of bortezomib and concurrent external beam radiation in patients with advanced solid malignancies. Pugh TJ, Chen C, Rabinovitch R, Eckhardt SG, Rusthoven KE, Swing R, Raben D. Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):521-6
  • Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/ II breast carcinoma. Vicini F, Winter K, Wong J, Pass H, Rabinovitch R, Chafe S, Arthur D, Petersen I, White J, McCormick B. Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1120-7
  • Accelerated Partial-Breast Irradiation: Trial by Media or by Science? Cuttino LW,White JR, Rabinovitch R, Gewirtz DA, Anscher MS, Wazer DE, Vicini FA, Julian TB, Douglas W. Arthur DW. Int J Radiat Oncol Biol Phys 2012 In press
  • Siziopikou KP, Anderson SJ, Cobleigh MA, Julian TB, Arthur DW, Zheng P, Mamounas EP, Pajon ER, Behrens RJ, Eakle JF, Leasure NC, Atkins JN, Polikoff JA, Seay TE, McCaskill-Stevens WJ, Rabinovitch R, Costantino JP, Wolmark N. Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43. Breast Cancer Res Treat. 2013 Nov;142(2):415-21. PubMed PMID: 24202240
  • Fields EC, DeWitt P, Fisher CM, Rabinovitch R. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis. Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):747-52. PubMed PMID: 24138917
  • Fields EC, Rabinovitch R, Ryan NE, Miften M, Westerly DC. A detailed evaluation of TomoDirect 3DCRT planning for whole-breast radiation therapy. Med Dosim. 2013 Winter;38(4):401-6. PubMed PMID: 23809692
  • Chafe S, Moughan J, McCormick B, Wong J, Pass H, Rabinovitch R, Arthur DW, Petersen I, White J, Vicini FA. Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: a phase 2 trial of 3-dimensional conformal radiation therapy-accelerated partial breast irradiation following lumpectomy for stages I and II breast cancer. Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):854-9. PubMed PMID: 23726000
  • Wolden SL, Rabinovitch RA, Bittner NH, Galvin JM, Giap HB, Schomberg PJ, Rosenthal SA, American College of Radiology, American Society for Radiation Oncology. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for the performance of total body irradiation (TBI). Am J Clin Oncol. 2013 Feb;36(1):97-101. PubMed PMID: 23334484
  • Preliminary results of centralized HER-2 testing in high-risk ductal carcinoma-in-situ (DCIS) of the breast: Early report from the NSABP B-43 clinical trial. Siziopikou KP, Anderson SJ, Cobleigh MA, Thomas B Julian TB, Arthur DW, Zheng P, Mamounas EP, Pajon ER, Behrens RJ, Chu L, Leasure NC, Atkins JN, Jonathan Polikoff J, Seay TE, McCaskill-Stevens WJ, Rabinovitch R, and Wolmark N. Early report from the NSABP B-43 clinical trial. Submitted J Clin Oncol April 2012
  • Rabinovitch R, Winter K, Kuske R, Bolton J, Arthur D, Scroggins T, Vicini F, McCormick B, White J. RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma--year-5 toxicity and cosmesis. Brachytherapy. 2014 Jan-Feb;13(1):17-22. PubMed PMID: 24041956
  • Kavanagh BD, Rabinovitch R, Mohideen N. Improved cosmesis in early breast cancer using conformal radiotherapy. J Clin Oncol. 2013 Dec 20;31(36):4483-4. PubMed PMID: 24248685
  • Early Toxicity Results with 3-D Conformal Radiotherapy (3D-CRT) from the NSABP B-39/RTOG 0413 Accelerated Partial Breast Irradiation (APBI) Trial. Julian TB, Vicini FA, Costantino JF, White JR, Arthur DW, Winter KA, Kuske RR, Rabinovitch R, Parda DS, Mamounas EP, Curran WJ, Wolmark N: Submitted J Clin Oncol December 2011
  • Advances in treatment techniques: stereotactic body radiation therapy and the spread of hypofractionation. Kavanagh BD, Miften M, and Rabinovitch RA: Cancer J. 2011 May-Jun;17(3):177-81
  • Cardiac Mortality in Patients with Stages I and II Diffuse Large B-Cell Lymphoma Treated with Radiation: A Surveillance, Epidemiology, and End-Results (SEER) Analysis. Pugh TJ, Ballonoff A, Rusthoven KE, McCammon R, Kavanagh B, Rabinovitch R: Int J Radiat Oncol Biol Phys 2010 Mar 1;76(3):845-9. Epub 2009 Jun 8
  • Improved Outcomes with Radiotherapy in Stage I-II Primary Mediastinal B-Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis Matthew W. Jackson MD, Chad G. Rusthoven MD, and Rachel Rabinovitch MD ASTRO Oral Presentation 2014
  • Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Czuczman MS, Fayad LE, Fisher RI, Glenn MJ, Harris NL, Hoppe RT, Horwitz SM, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Saad AA, Sokol L, Swinnen LJ, Tsien C, Vose JM, Yahalom J, Zafar N, Dwyer M, Sundar H. Non-Hodgkin's lymphomas, version 4.2014. J Natl Compr Canc Netw. 2014 Sep;12(9):1282-303. PubMed PMID: 25190696
  • Fisher CM, Rabinovitch R. Frontiers in radiotherapy for early-stage invasive breast cancer. J Clin Oncol. 2014 Sep 10;32(26):2894-901. PubMed PMID: 25113764
  • Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Bellam N, Byrd JC, Czuczman MS, Fayad LE, Fisher RI, Glenn MJ, Harris NL, Hoppe RT, Horwitz SM, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Sokol L, Swinnen LJ, Tsien C, Vose JM, Yahalom J, Zafar N, Dwyer M, Sundar H. Non-Hodgkin's lymphomas, version 2.2014. J Natl Compr Canc Netw. 2014 Jun;12(6):916-46. PubMed PMID: 24925202
  • Qi XS, Liu TX, Liu AK, Newman F, Rabinovitch R, Kavanagh B, Hu YA. Left-sided breast cancer irradiation using rotational and fixed-field radiotherapy. Med Dosim. 2014 Autumn;39(3):227-34. PubMed PMID: 24857697
  • Early stage BRCA-2 associated breast cancer diagnosed in the first trimester of pregnancy associated with a hypercoagulable state. Diamond JR, Finlayson CA, Thienelt C, Kabos P, Hardesty L, Barbour L, Klein CE, Rabinovitch R, Elias A, Borges V: Oncology 2009 In Press
  • Lauro C, Fisher C and Rabinovitch R: Breast Cancer Risk Assessment and Chemoprevention: Results of a Survey. ASTRO 2013
  • Breast Cancer Contouring Atlas. White J, Tai A, Arthur D, Buchholz T, MacDonald S, Marks L, Pierce, Recht A, Rabinovitch R, Taghian A, Vicini F, Woodward W, Li AX: http://rtog.org/pdf_file2.html?pdf_document=BreastCancerAtlas.pdf
  • Prophylactic Cranial Irradiation (PCI) Collaborative Group: Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. Le Péchoux C, Dunant A, Senan S, Wolfson A, Quoix E, Faivre-Finn C, Ciuleanu T, Arriagada R, Jones R, Wanders R, Lerouge D, Laplanche A; Lancet Oncol. 2009 May;10(5):467-74. Epub 2009 Apr 20 (Rabinovitch R listed as collaborator).
  • Double helix of breast cancer therapy: intertwining the halsted and fisher hypotheses. Rabinovitch R and Kavanagh B: J Clin Oncol. 2009 May 20;27(15):2422-3. Epub 2009 Apr 6.
  • Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Tsien C, Winter JN, Yahalom J, Burns JL, Sundar H. Hodgkin lymphoma, version 2.2015. J Natl Compr Canc Netw. 2015 May;13(5):554-86. PubMed PMID: 25964641
  • Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Czuczman MS, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Harris NL, Hoppe RT, Horwitz SM, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Saad AA, Sokol L, Swinnen LJ, Tsien C, Vose JM, Wilson L, Yahalom J, Zafar N, Dwyer M, Sundar H. Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015. J Natl Compr Canc Netw. 2015 Mar;13(3):326-62. PubMed PMID: 25736010
  • Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Czuczman MS, Fayad LE, Fisher RI, Glenn MJ, Harris NL, Hoppe RT, Horwitz SM, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Saad AA, Sokol L, Swinnen LJ, Tsien C, Vose JM, Yahalom J, Zafar N, Dwyer M, Sundar H. Non-Hodgkin's lymphomas, version 4.2014. J Natl Compr Canc Netw. 2014 Sep;12(9):1282-303. PubMed PMID: 25190696
  • Jackson MW, Rusthoven CG, Jones BL, Kamdar M, Rabinovitch R. Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis. Int J Radiat Oncol Biol Phys. 2015 Sep 25. pii: S0360-3016(15)03347-7. doi: 10.1016/j.ijrobp.2015.09.017. Forthcoming 2016
  • ACR Appropriateness Criteria(R) on Postmastectomy Radiotherapy Expert Panel on Radiation Oncology-Breast. Taylor ME, Haffty BG, Rabinovitch R, Arthur DW, Halberg FE, Strom EA, White JR, Cobleigh MA, Edge SB: Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):997-1002
  • Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. Li XA, Tai A, Arthur DW, Buchholz TA, Macdonald S, Marks LB, Moran JM, Pierce LJ, Rabinovitch R, Taghian A, Vicini F, Woodward W, White JR; Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):944-51
  • Jasem J, Amini A, Rabinovitch R, Borges VF, Elias A, Fisher CM, Kabos P. 21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile. J Clin Oncol. 2016 Jun 10;34(17):1995-2002. PubMed PMID: 27001563
  • A perimenopausal woman with a small, ER/HER2-positive, node-negative breast cancer. Brooks G, Borges V, Singh M, Rabinovitch R, Finlayson C, Elias A. Oncology (Williston Park). 2008 Oct;22(11):1270-6. No abstract available.
  • Shaitelman SF, Amendola B, Khan A, Beriwal S, Rabinovitch R, Demanes DJ, Kim LH, Cuttino L. American Brachytherapy Society Task Group Report: Long-term control and toxicity with brachytherapy for localized breast cancer. Brachytherapy. 2016 Jun 7. [Epub ahead of print] PubMed PMID: 27288156
  • American College of Radiology appropriateness criteria on conservative surgery and radiation: stages I and II breast carcinoma. White JR, Halberg FE, Rabinovitch R, Green S, Haffty BG, Solin LJ, Strom EA, Taylor ME, Edge SB: J Am Coll Radiol. 2008 Jun;5(6):701-13.
  • Jackson MW, Rusthoven CG, Jones BL, Kamdar M, Rabinovitch R. Improved survival with combined modality therapy in the modern era for primary mediastinal B-cell lymphoma. Am J Hematol. 2016 May;91(5):476-80. PubMed PMID: 26852276
  • Rusthoven CG, Rabinovitch RA, Jones BL, Koshy M, Amini A, Yeh N, Jackson MW, Fisher CM. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis. Ann Oncol. 2016 May;27(5):818-27. PubMed PMID: 26861597
  • Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Lee Harris N, Hernandez-Ilizaliturri F, Hoppe RT, Horwitz SM, Kaminski MS, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Lunning M, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Roberts K, Saad AA, Sokol L, Swinnen LJ, Vose JM, Yahalom J, Zafar N, Dwyer M, Sundar H. Diffuse Large B-Cell Lymphoma Version 1.2016. J Natl Compr Canc Netw. 2016 Feb;14(2):196-231. PubMed PMID: 26850490
  • Jackson MW, Rusthoven CG, Jones BL, Kamdar M, Rabinovitch R. Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis. Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):126-32. PubMed PMID: 26547384
  • Impact of Post-mastectomy Radiotherapy in T3N0 Invasive Carcinoma of the Breast: A Surveillance, Epidemiology, and End-Results (SEER) Database Analysis. McCammon R, Finlayson C, Schwer A, Rabinovitch R: Cancer 2008 Aug 15;113(4):683-9
  • Quackenbush K, Amini A, Fisher CM, Rabinovitch R. Regression of a Fungating Tumor After Hypofractionated Radiation Therapy in a Patient With Metastatic Breast Cancer. Cureus. 2017 Jul 2;9(7):e1417. PubMed PMID: 28875090
  • Stokes WA, Amini A, Jackson MW, Plimpton SR, Kounalakis N, Kabos P, Rabinovitch RA, Rusthoven CG, Fisher CM. Patterns of Fractionation and Boost Usage in Adjuvant External Beam Radiotherapy for Ductal Carcinoma in Situ in the United States. Clin Breast Cancer. 2017 Jun 29. [Epub ahead of print] PubMed PMID: 28797765
  • Brown RJ, Sams S, Wolverton DE, Chong T, Borges VF, Rabinovitch RA, Murphy CD. Don't Be Fooled by DCIS. Oncology (Williston Park). 2017 Jul 15;31(7):549-51, 560-1. PubMed PMID: 28712099
  • Melani C, Major A, Schowinsky J, Roschewski M, Pittaluga S, Jaffe ES, Pack SD, Abdullaev Z, Ahlman MA, Kwak JJ, Morgan R, Rabinovitch R, Pan Z, Haverkos BM, Gutman JA, Pollyea DA, Smith CA, Wilson WH, Kamdar M. PD-1 Blockade in Mediastinal Gray-Zone Lymphoma. N Engl J Med. 2017 Jul 6;377(1):89-91. PubMed PMID: 28679093
  • A Phase II Trial of Brachytherapy Alone Following Lumpectomy for Select Breast Cancer: tumor control and survival outcomes of RTOG 95-17. Arthur DW, Winter K, Kuske RR, Bolton J, Rabinovitch R, White J, Hanson W, Wilenzick RM, McCormick B,: Int J Radiat Biol Phys 2008 Oct 1;72(2):467-73.
  • Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bernat K, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Smith M, Winter JN, Yahalom J, Burns J, Ogba N, Sundar H. Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 May;15(5):608-638. PubMed PMID: 28476741
  • Jasem J, Fisher CM, Amini A, Shagisultanova E, Rabinovitch R, Borges VF, Elias A, Kabos P. The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?. J Natl Compr Canc Netw. 2017 Apr;15(4):494-503. PubMed PMID: 28404760
  • Wierda WG, Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Caimi P, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Harris NL, Hernandez-Ilizaliturri F, Hoppe RT, Horwitz SM, Kaminski MS, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Martin MG, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Roberts K, Saad AA, Snyder ED, Sokol L, Swinnen LJ, Vose JM, Yahalom J, Dwyer MA, Sundar H. NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017. J Natl Compr Canc Netw. 2017 Mar;15(3):293-311. PubMed PMID: 28275031
  • Outcomes and impact of radiotherapy in Patients with Stages I and II Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy: A Surveillance, Epidemiology and End Results (SEER) Analysis. Ballonoff A, Rusthoven K, Schwer A, McCammon R, Kavanagh B, Bassetti M, Newman F, Rabinovitch R: Int J Radiat Bio Phys 2008 Apr 1;70(5):1468-71
  • Evaluation of Breast Sentinel Lymph Node Coverage by Standard Radiation Therapy Fields. Rabinovitch R, Ballonoff A, Newman F, Finlayson C: Int J Radiat Oncol Bio Phys; 2008 Apr 1 70(5):1468-1471.
  • Lawton CAF, Lin X, Hanks GE, Lepor H, Grignon DJ, Brereton HD, Bedi M, Rosenthal SA, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Kim H, Parliament MB, Rabinovitch R, Roach M 3rd, Kwok Y, Dignam JJ, Sandler HM. Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202. Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):296-303. PubMed PMID: 28463149
  • Shaitelman SF, Amendola B, Khan A, Beriwal S, Rabinovitch R, Demanes DJ, Kim LH, Cuttino L. American Brachytherapy Society Task Group Report: Long-term control and toxicity with brachytherapy for localized breast cancer. Brachytherapy. 2017 Jan - Feb;16(1):13-21. PubMed PMID: 27288156
  • ACR practice guideline for the performance of screening and diagnostic mammography. Bassett LW, Berg WA, Birdwell RL, Brenner RJ, MD, Comstock CE, D’Orsi CJ, DeBruhl ND, Evans WP, Everson LI, Farria DM, Harvey JA, Herman CR, Jong RA, Kaplan SS, Liberman L, Mahoney MC, Mendelson EB, Morris EA, Parikh JR, Rabinovitch RA, Rosen EL, Lee CH. 2008 Practice Guidelines and Technical Standards, pp 525-534, American College of Radiology
  • ACR Practice Guideline for the Performance of Contrast-Enhanced Magnetic Resonance Imaging (MRI) of the Breast. Bassett LW, Berg WA, Birdwell RL, Brenner RJ, MD, Comstock CE, D’Orsi CJ, DeBruhl ND, Evans WP, Everson LI, Farria DM, Harvey JA, Herman CR, Jong RA, Kaplan SS, Liberman L, Mahoney MC, Mendelson EB, Morris EA, Parikh JR, Rabinovitch RA, Rosen EL, Lee CH. 2008 Practice Guidelines and Technical Standards, pp 561-567, American College of Radiology
  • Conservative Surgery and Radiation-Stage I and II Breast Carcinoma. White J, Halberg F, Rabinovitch R, Green S, Hafty B, Solin L, Strom E, Taylor M, Edge S: J Amer College Radiol 2008
  • Dose Specification and Quality Assurance of Radiation Therapy Oncology Group Protocol 95-17; A Cooperative Group Study of 192 Ir Breast Implants as Sole Therapy. Ibbot G, Hanson WF, Omeara E, Kuske R, Arthur D, Rabinovitch R, White J, Wilenzick RM, Harris I, Tailor RC: Int J Radiat Oncol Bio Phys; 2007 Dec 1;69(5):1572-8.
  • Hodgkin Lymphoma Associated Vanishing Bile Duct Syndrome: case report and review of the literature. Ballonoff A, Kavanagh B, Nash R, Drabkin H, Trotter J, Costa L, Rabinovitch R: Acta Oncol, 2007 47(5):962-70
  • A young woman with a small ER-positive breast cancer, a micrometastatic axillary lymph node, and an intermediate oncotype DX recurrence score. Bowles DW, Rabinovitch R, Borges V, Urquhart A, Singh M, Finlayson C, Elias A: Oncology 2007 Sep;21(10):1212-7
  • Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. Lancet Oncol. 2018 Nov;19(11):1504-1515. doi: 10.1016/S1470-2045(18)30528-X. Epub 2018 Oct 10. Erratum in: Lancet Oncol. 2018 Nov;19(11):e581. PubMed PMID: 30316827.
  • Reply to letter to the editor. Rabinovitch R, Berkey B, Raben D, Cooper J: Head Neck 2007 May;29(5):519-2
  • Tacrolimus and mycophenolate mofetil after non-myeloablative matched sibling donor allogeneic stem-cell transplants conditioned with fludarabine and low-dose total body irradiation. Nieto Y, Patton N, Hawkins T. Spearing R. Bearman SI, Jones RB, Shpall EJ, Rabinovitch R, Zeng C, Baron A, McSweeney PA: Blood and Bone Marrow Transplant 2006 Feb;12(2):217-25
  • Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03. Rabinovitch R, Grant B, Berkey BA, Raben D, Ang KK, Fu KK, Cooper JS, Radiation Oncology Group: Head Neck. 2006 Apr;28(4):287-96
  • A Phase II Trial of Brachytherapy Alone Following Lumpectomy for Select Breast Cancer: Toxicity Analysis of RTOG 95-17. Kuske R, Winter K, Arthur D, Bolton J, Rabinovitch R, White J, Hanson W, Wilenzick RM: Int J Radiat Oncol Bio Phys 2006 65(1);45-51.
  • Phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer. Sunpaweravong P, Magree L, Rabinovitch R, Bunn P, Kelly K Invest New Drugs. 2005 24(3):213-21
  • A Phase I/II Trial To Evaluate Three Dimensional Conformal Radiation Therapy (3D-CRT) Confined To The Region Of The Lumpectomy Cavity For Stage I/ II Breast Carcinoma: Initial Report of Feasibility and Reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Vicini F, Winter K, Straube W, Wong J, Pass H, Rabinovitch R, Chafe S, Arthur D, Peterson I, McCormick B: Int J Radiat Oncol Bio Phys 2005 63(5):1531-7.
  • Seider MJ, Pugh SL, Langer C, Wyatt G, Demas W, Rashtian A, Clausen CL, Derdel JD, Cleary SF, Peters CA, Ramalingam A, Clarkson JE, Tomblyn M, Rabinovitch RA, Kachnic LA, Berk LB; NRG Oncology.. Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial. Ann Nucl Med. 2018 Oct;32(8):553-560. doi: 10.1007/s12149-018-1278-4. Epub 2018 Aug 9. PubMed PMID: 30094545; PubMed Central PMCID: PMC6245542.
  • Ductal carcinoma in situ and microinvasive disease. Rabinovitch R, Solin LJ, Shank BM, et al: American College of Radiology ACR Appropriateness CriteriaTM. 2006
  • A woman with breast cancer and solitary sternal metastasis. Menter A, Urquhart A, Borges V, Rabinovitch R, Singh M, Robinson W, Seligman P, Finlayson C, Elias A: 2006 Oncology 20(9):1068-1080, 2006
  • Expert panel on Radiation Oncology-Breast Work Group. Rabinovitch R, Solin LJ, Shank B, et al: in situ American College of Radiology Appropriateness Criteria, June 30, 2006.
  • Local regional (LR) recurrence and salvage surgery - breast cancer. Green S, Shank MB, Haffty BG, Halberg FE, Mitchell SE, Rabinovitch R, Solin LJ, Strom EA, Taylor ME, White JR, Cobleigh MA, Edge AB, Mauch PM: Expert panel on Radiation Oncology-Breast Work Group. American College of Radiology Appropriateness Criteria, June 30, 2006.
  • Mammosite brachytherapy – evolution and current status. Rabinovitch R, Schwer A, In Breast Cancer Online. 2006 December issue, www.bco.org
  • Sharma P, Pollyea DA, Smith CA, Purev E, Kamdar M, Haverkos B, Sherbenou D, Rabinovitch R, Hammes A, Gutman JA. Thiotepa-Based Intensified Reduced-Intensity Conditioning Adult Double-Unit Cord Blood Hematopoietic Stem Cell Transplantation Results in Decreased Relapse Rate and Improved Survival Compared with Transplantation Following Standard Reduced-Intensity Conditioning: A Retrospective Cohort Comparison. Biol Blood Marrow Transplant. 2018 Aug;24(8):1671-1677. doi: 10.1016/j.bbmt.2018.04.019. Epub 2018 Apr 21. PubMed PMID: 29684565.
  • A postmenopausal woman with early stage breast cancer and borderline hormone receptor staining. Urquhart A, Borges V, Rabinovitch R, Singh M, Robinson W, Seligman P, Arya J, Finlayson C, Elias A: Oncology Mar;19(3):278, 283-4, 2005
  • A Breast Cancer Research Field of Dreams: If we build it, will they come? Rabinovitch, R: Editorial in Clin Breast Cancer, 2005 Apr;6(1):11-2
  • Report of the Working Groups on Breast MRI: Report of the Breast Cancer Staging Group. Harms SE, Rabinovitch R, Julian TB, Rafferty E, Masood S, Weatherall P: Breast J 10(supp 2):3-8, 2004
  • Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemia with secondary hemochromatosis. Medeiros BC, Kolhouse JF, Cagnoni PJ, Ryder J, Nieto Y, Rabinovitch R, Shpall EJ, Bearnam SI, Jones RB, McSweeney PA: Bone Marrow Transplant 2003 Jun;31(11):1053-5.
  • Intensive chemotherapy for progressive chronic lymphocytic leukemia administered early after a nonmyeloablative allograft. Nieto Y, Bearman SI, Shpall EJ, Jones RB, Cagnoni PJ, Rabinovitch R, McSweeney PA: 2001 Bone Marrow Transplant 28(11):1083-6.
  • Radiation therapy oncology group. Research plan 2002-2006. Breast cancer working group. McCormick B, Strom E, Craighead PS, Kuske R, Hedis C, Ley J, Margolis L, Meyerowitz B, Morris E, Petrek J, Pierce L, Pisansky T, Rabinovitch R, Sneige N, Vicini F, Unger D, Winter K: 2001 Int J Radiat Oncol Biol Phys 51(3 Suppl 2): 56-7.
  • Postmastectomy radiotherapy. Taylor ME, Haffty BG, Shank BM, Halberg FE, Martinez AA, McCormick B, McNeese MD, Mendenhall NP, Mitchell SE, Rabininovitch R, Solin LJ, Singletary SE, Leibel S. Recht A.: American College of Radiology ACR Appropriateness CriteriaTM 2000. Radiology 215(suppl):1153-1170, 2000.
  • Ductal carcinoma in situ and microinvasive disease. Rabinovitch R, Solin LJ, Shank BM, Haffty BG, Halberg FE, Martinez AA, McCormick B, McNeese MD, Mendenhall NP, Mitchell SE, Taylor ME, Singletary SE, Leibel S.: American College of Radiology ACR Appropriateness CriteriaTM 2000. Radiology 215(suppl): 1137-1152, 2000.
  • Locally advanced breast cancer. McNeese MD, Mitchell SE, Shank BM, Haffty BG, Halberg FE, Martinez AA, McCormick B, Mendenhall NP, Rabinovitch R, Solin LJ, Taylor ME, Singletary SE, Leibel S. American College of Radiology ACR Appropriateness CriteriaTM 2000. Radiology 215(suppl):1171-1180, 2000.
  • Local regional recurrence and salvage surgery. McCormick B, Mendenhall NP, Shank BM, Haffty BG, Halberg FE, Martinez AA, McNeese MD, Mitchell SE, Rabinovitch R, Solin LJ, Taylor ME, Singeltary SE, Leibel S.: American College of Radiology ACR Appropriateness CriteriaTM 2000. Radiology 215(suppl):1181-1192, 2000.
  • Conservative surgery and radiation in the treatment of stage I and II carcinoma of the breast. Halberg FE, Shank BM, Haffty BG, Martinez AA, McCormick B, McNeese MD, Mendenhall NP, Mitchell SE, Rabinovitch R, Solin RJ, Taylor ME, Singletary SE, Leibel S: American College of Radiology ACR Appropriateness CriteriaTM 2000, Radiology 215(suppl):1193-1205, 2000.
  • Radiographic evaluation of surgical clips is better than ultrasound for defining the lumpectomy cavity in breast boost treatment planning: a prospective clinical study. Rabinovitch R, Finlayson C, Pan Z, Lewin J, Humphries S, Biffl W, Franciose R 2000 Int J Radiat Oncol Biol Phys 47(2):313-317.
  • Breast conservation therapy in affiliated county, university, and private hospitals. Heimbach JK, Biffl WL, Mitchell EL, Finlayson CA, Schwartzberg BS, Myers A, Rabinovitch R, Franciose R: 1999 Amer J Surg 178(6):466-9.
  • ACR appropriateness criteria Expert panel on radiation oncology. Leibel SA. American college of radiology. Int J Radiat Oncol Biol Phys 43(1):125-68, 1999. (Rabinovitch R is member of Expert Panel for this project)
  • Appropriateness criteria for the treatment of ductal carcinoma in situ and DCIS with microinvasion, in American college of Radiology Appropriateness Criteria 1997. Rabinovitch R , Solin L: Radiation Oncology, Reston: American College of Radiology, 1997
  • Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. Rabinovitch R, Zelefsky MJ, Gaynor JJ, Fuks Z: 1994 J Clin Oncol 11:206-212.
  • Review of “Conformal high dose radiation plus intraarterial floxuridine for hepatic cancer” by Lawrence T, Kessler M, and Robertson J., Rabinovitch R: Oncol 7:58-63, 1993
  • A woman with primary breast cancer and a solitary sternal metastasis. 1. Menter A, Urquhart A, Borges V, Rabinovitch R, Singh M, Robinson W, Seligman P, Finlayson C, Elias A: Oncology (Williston Park) 2006 Aug;20(9): 1068-71, 1075, 1-79-80.
  • Stokes WA, Amini A, Jackson MW, Plimpton SR, Kounalakis N, Kabos P, Rabinovitch RA, Rusthoven CG, Fisher CM. Patterns of Fractionation and Boost Usage in Adjuvant External Beam Radiotherapy for Ductal Carcinoma in Situ in the United States. Clin Breast Cancer. 2018 Jun;18(3):220-228. doi: 10.1016/j.clbc.2017.06.009. Epub 2017 Jun 29. PubMed PMID: 28797765.
  • Erickson BA, Demanes DJ, Ibbott GS, Hayes JK, Hsu IC, Morris DE, Rabinovitch RA, Tward JD, Rosenthal SA. American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Performance of High-Dose-Rate Brachytherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):641-9
  • Willett CG, Moughan J, O'Meara E, Galvin JM, Crane CH, Winter K, Manfredi D, Rich TA, Rabinovitch R, Lustig R, Machtay M, Curran WJ. Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials. Radiother Oncol. 2012 105(1):9-13
  • Wolden SL, Rabinovitch RA, Bittner NH, Galvin JM, Giap HB, Schomberg PJ, Rosenthal SA. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for the performance of total body irradiation (TBI). Am J Clin Oncol. 2013 Feb;36(1):97-101
  • Cuttino LW,White JR, Rabinovitch R, Gewirtz DA, Anscher MS, Wazer DE, Vicini FA, Julian TB, Douglas W. Arthur DW: Accelerated Partial-Breast Irradiation: Trial by Media or by Science? Int J Radiat Oncol Biol Phys 2012 2012 Jul 15;83(4):1075-7
  • Fields EC, DeWitt PE, Fisher CM, Rabinovitch R: Male Breast Cancer in the United States: A surveillance, Epidemiology and End Results Analysis. Int J Radiat Oncol Bio Phys 84(3S); abstract 1060, 2012
  • Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Armand P, Bello CM, Benitez CM, Bierman PJ, Chen R, Dabaja B, Dean R, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maddocks K, Maloney DG, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Rabinovitch R, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N. NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018. J Natl Compr Canc Netw. 2018 Mar;16(3):245-254. doi: 10.6004/jnccn.2018.0013. PubMed PMID: 29523663.
  • Fields EC, Plimpton SR, Fisher CM, Liu AK, Kavanagh BK, and Rabinovitch R: Rethinking the Supraclavicular Field: Anterior Wedged Pair 3D Conformal Radiation Therapy Versus Single Anterior Oblique Field as Treatment of the Axillary Apex and Supraclavicular Fossa in Node Positive Breast Cancer. Int J Radiat Oncol Bio Phys 84(3S); abstract 2062, 2012
  • Cobleigh MA, Anderson SJ, Julian TJ, Siziopikou KP, Arthur DW, Rabinovitch R, Zheng P, Mamounas EP, and Wolmark N: NSABP B-43: A phase III clinical trial to compare trastuzumab (T) given concurrently with radiation therapy (RT) to RT alone for women with HER2+ DCIS resected by lumpectomy (Lx)." Cancer Res. 2012;72(24) Suppl 3: Abstract nr OT1-2-01. Abstract from the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium-- Dec 4-8, 2012; San Antonio, TX
  • Major A, Jackson MW, Smith DE, Kamdar M, Rabinovitch R. Inferior outcomes and treatment disparities in elderly patients with classical Hodgkin lymphoma: a national cancer data base analysis. Leuk Lymphoma. 2018 Dec 3:1-10. doi: 10.1080/10428194.2018.1522435. [Epub ahead of print] PubMed PMID: 30501432.
  • Vicini FA, Cecchini RS, White JR, Arthur DW, Julian TB, Rabinovitch RA, Kuske RR, Ganz PA, Parda DS, Scheier MF, Winter KA, Paik S, Kuerer HM, Vallow LA, Pierce LJ, Mamounas EP, McCormick B, Costantino JP, Bear HD, Germain I, Gustafson G, Grossheim L, Petersen IA, Hudes RS, Curran WJ Jr, Bryant JL, Wolmark N. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. Lancet. 2019 Dec 14;394(10215):2155-2164. PubMed PMID: 31813636
  • Major A, Smith DE, Ghosh D, Rabinovitch R, Kamdar M. Risk and subtypes of secondary primary malignancies in diffuse large B-cell lymphoma survivors change over time based on stage at diagnosis. Cancer. 2020 Jan 1;126(1):189-201. PubMed PMID: 31509235
  • Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Bartlett NL, Caimi PF, Chang JE, Chavez JC, Christian B, Fayad LE, Glenn MJ, Habermann TM, Lee Harris N, Hernandez-Ilizaliturri F, Kaminski MS, Kelsey CR, Khan N, Krivacic S, LaCasce AS, Mehta A, Nademanee A, Rabinovitch R, Reddy N, Reid E, Roberts KB, Smith SD, Snyder ED, Swinnen LJ, Vose JM, Dwyer MA, Sundar H. NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019. J Natl Compr Canc Netw. 2019 Jun 1;17(6):650-661. PubMed PMID: 31200358
  • Stumpf PK, Cittelly DM, Robin TP, Carlson JA, Stuhr KA, Contreras-Zarate MJ, Lai S, Ormond DR, Rusthoven CG, Gaspar LE, Rabinovitch R, Kavanagh BD, Liu A, Diamond JR, Kabos P, Fisher CM. Combination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4. Clin Cancer Res. 2019 Jul 1;25(13):3946-3953. PubMed PMID: 30940654
  • Major A, Jackson MW, Smith DE, Kamdar M, Rabinovitch R. Inferior outcomes and treatment disparities in elderly patients with classical Hodgkin lymphoma: a national cancer data base analysis. Leuk Lymphoma. 2019 May;60(5):1234-1243. PubMed PMID: 30501432
  • Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. Lancet Oncol. 2018 Nov;19(11):1504-1515. PubMed PMID: 30316827
  • Seider MJ, Pugh SL, Langer C, Wyatt G, Demas W, Rashtian A, Clausen CL, Derdel JD, Cleary SF, Peters CA, Ramalingam A, Clarkson JE, Tomblyn M, Rabinovitch RA, Kachnic LA, Berk LB. Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial. Ann Nucl Med. 2018 Oct;32(8):553-560. PubMed PMID: 30094545
  • Hadar T, Mor P, Amit G, Lieberman S, Gekhtman D, Rabinovitch R, Levy-Lahad E. Presymptomatic Awareness of Germline Pathogenic BRCA Variants and Associated Outcomes in Women With Breast Cancer. JAMA Oncol. 2020 Sep 1;6(9):1460-1463. PubMed PMID: 32644100
  • Sharma P, Pollyea DA, Smith CA, Purev E, Kamdar M, Haverkos B, Sherbenou D, Rabinovitch R, Hammes A, Gutman JA. Thiotepa-Based Intensified Reduced-Intensity Conditioning Adult Double-Unit Cord Blood Hematopoietic Stem Cell Transplantation Results in Decreased Relapse Rate and Improved Survival Compared with Transplantation Following Standard Reduced-Intensity Conditioning: A Retrospective Cohort Comparison. Biol Blood Marrow Transplant. 2018 Aug;24(8):1671-1677. PubMed PMID: 29684565
  • Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, Benitez CM, Bierman PJ, Boughan KM, Dabaja B, Gordon LI, Hernandez-Ilizaliturri FJ, Herrera AF, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Lynch RC, Maddocks K, McConathy J, McKinney M, Metzger M, Morgan D, Mulroney C, Rabinovitch R, Rosenspire KC, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N. Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Jun;18(6):755-781. PubMed PMID: 32502987
  • Sharma P, Purev E, Haverkos B, Pollyea DA, Cherry E, Kamdar M, Mark T, Forsberg P, Sherbenou D, Hammes A, Rabinovitch R, Smith CA, Gutman JA. Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant. Blood Adv. 2020 May 26;4(10):2227-2235. PubMed PMID: 32442301
  • Thomas DH, Miller B, Rabinovitch R, Milgrom S, Kavanagh B, Diot Q, Miften M, Schubert LK. Integration of automation into an existing clinical workflow to improve efficiency and reduce errors in the manual treatment planning process for total body irradiation (TBI). J Appl Clin Med Phys. 2020 Jul;21(7):100-106. PubMed PMID: 32426947
  • Schlosser S, Rabinovitch R, Shatz Z, Galper S, Shahadi-Dromi I, Finkel S, Jacobson G, Rasco A, Friedman E, Laitman Y, Evron E, Bernstein R, Weiss I, Sklair-Levy M, Ben-David MA. Radiation-Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast Cancer. Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):353-359. PubMed PMID: 32084523
  • Vicini FA, Cecchini RS, White JR, Arthur DW, Julian TB, Rabinovitch RA, Kuske RR, Ganz PA, Parda DS, Scheier MF, Winter KA, Paik S, Kuerer HM, Vallow LA, Pierce LJ, Mamounas EP, McCormick B, Costantino JP, Bear HD, Germain I, Gustafson G, Grossheim L, Petersen IA, Hudes RS, Curran WJ Jr, Bryant JL, Wolmark N. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. Lancet. 2019 Dec 14;394(10215):2155-2164. PubMed PMID: 31813636
  • Major A, Smith DE, Ghosh D, Rabinovitch R, Kamdar M. Risk and subtypes of secondary primary malignancies in diffuse large B-cell lymphoma survivors change over time based on stage at diagnosis. Cancer. 2020 Jan 1;126(1):189-201. PubMed PMID: 31509235
  • Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Bartlett NL, Caimi PF, Chang JE, Chavez JC, Christian B, Fayad LE, Glenn MJ, Habermann TM, Lee Harris N, Hernandez-Ilizaliturri F, Kaminski MS, Kelsey CR, Khan N, Krivacic S, LaCasce AS, Mehta A, Nademanee A, Rabinovitch R, Reddy N, Reid E, Roberts KB, Smith SD, Snyder ED, Swinnen LJ, Vose JM, Dwyer MA, Sundar H. NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019. J Natl Compr Canc Netw. 2019 Jun 1;17(6):650-661. PubMed PMID: 31200358
  • Stumpf PK, Cittelly DM, Robin TP, Carlson JA, Stuhr KA, Contreras-Zarate MJ, Lai S, Ormond DR, Rusthoven CG, Gaspar LE, Rabinovitch R, Kavanagh BD, Liu A, Diamond JR, Kabos P, Fisher CM. Combination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4. Clin Cancer Res. 2019 Jul 1;25(13):3946-3953. PubMed PMID: 30940654
  • Major A, Jackson MW, Smith DE, Kamdar M, Rabinovitch R. Inferior outcomes and treatment disparities in elderly patients with classical Hodgkin lymphoma: a national cancer data base analysis. Leuk Lymphoma. 2019 May;60(5):1234-1243. PubMed PMID: 30501432
  • https://pubmed.ncbi.nlm.nih.gov/32084523/
  • Shiao JC, Wolf AB, Rabinovitch RA, Smith C, Kleinschmidt-DeMasters BK, Ney DE. Long-Term Control of Primary Cerebral ALH Amyloidoma With Focal Radiation Therapy. Adv Radiat Oncol. 2022 Mar-Apr;7(2):100831. PubMed PMID: 34934868
  • Zelenetz AD, Gordon LI, Chang JE, Christian B, Abramson JS, Advani RH, Bartlett NL, Budde LE, Caimi PF, De Vos S, Dholaria B, Fakhri B, Fayad LE, Glenn MJ, Habermann TM, Hernandez-Ilizaliturri F, Hsi E, Hu B, Kaminski MS, Kelsey CR, Khan N, Krivacic S, LaCasce AS, Lim M, Narkhede M, Rabinovitch R, Ramakrishnan P, Reid E, Roberts KB, Saeed H, Smith SD, Svoboda J, Swinnen LJ, Tuscano J, Vose JM, Dwyer MA, Sundar H. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021. J Natl Compr Canc Netw. 2021 Nov;19(11):1218-1230. PubMed PMID: 34781267
  • Pollyea DA, Winters A, McMahon C, Schwartz M, Jordan CT, Rabinovitch R, Abbott D, Smith CA, Gutman JA. Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60. Bone Marrow Transplant. 2021 Oct 13. [Epub ahead of print] PubMed PMID: 34645926
  • Jimenez RB, Rabinovitch RA. Caring for the Whole Patient After Breast Cancer Therapy: A Survivorship Guide for Radiation Oncologists. Pract Radiat Oncol. 2022 Jan-Feb;12(1):e1-e6. PubMed PMID: 34454104
  • Liveringhouse CL, Washington IR, Diaz R, Jimenez RB, Harris EE, Rabinovitch R, Woodward WA, Torres-Roca JF, Ahmed KA. Genomically Guided Breast Radiation Therapy: A Review of the Current Data and Future Directions. Adv Radiat Oncol. 2021 Jul-Aug;6(4):100731. PubMed PMID: 34409215
  • Cobleigh MA, Anderson SJ, Siziopikou KP, Arthur DW, Rabinovitch R, Julian TB, Parda DS, Seaward SA, Carter DL, Lyons JA, Dillmon MS, Magrinat GC, Kavadi VS, Zibelli AM, Tiriveedhi L, Hill ML, Melnik MK, Beriwal S, Mamounas EP, Wolmark N. Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial. J Clin Oncol. 2021 Jul 20;39(21):2367-2374. PubMed PMID: 33739848
  • Shah C, Bremer T, Cox C, Whitworth P, Patel R, Patel A, Brown E, Gold L, Rock D, Riley L, Kesslering C, Brown S, Gabordi R, Pellicane J, Rabinovich R, Khan S, Templeton S, Majithia L, Willey SC, Wärnberg F, Gerber NK, Shivers S, Vicini FA. The Clinical Utility of DCISionRT(®) on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery. Ann Surg Oncol. 2021 Oct;28(11):5974-5984. PubMed PMID: 33821346
  • Pollyea DA, Winters A, McMahon C, Schwartz M, Jordan CT, Rabinovitch R, Abbott D, Smith CA, Gutman JA. Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60. Bone Marrow Transplant. 2022 Feb;57(2):160-166. doi: 10.1038/s41409-021-01476-7. Epub 2021 Oct 13. PMID: 34645926.
  • Nguyen PL, Huang HR, Spratt DE, Davicioni E, Sandler HM, Shipley WU, Efstathiou JA, Simko JP, Pollack A, Dicker AP, Roach M, Rosenthal SA, Zeitzer KL, Mendez LC, Hartford AC, Hall WA, Desai AB, Rabinovitch RA, Peters CA, Rodgers JP, Tran P, Feng FY. Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials. Int J Radiat Oncol Biol Phys. 2022 Dec 31:S0360-3016(22)03688-4. doi: 10.1016/j.ijrobp.2022.12.035. Epub ahead of print. PMID: 36596347.
  • Rabinovitch RA. In Regard to Gillespie et al. Pract Radiat Oncol. 2022 May-Jun;12(3):e241-e242. doi: 10.1016/j.prro.2021.11.014. PMID: 35512993.
  • Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, Benitez CM, Chen W, Dabaja B, Daly ME, Gordon LI, Hansen N, Herrera AF, Hochberg EP, Johnston PB, Kaminski MS, Kelsey CR, Kenkre VP, Khan N, Lynch RC, Maddocks K, McConathy J, Metzger M, Morgan D, Mulroney C, Pullarkat ST, Rabinovitch R, Rosenspire KC, Seropian S, Tao R, Torka P, Winter JN, Yahalom J, Yang JC, Burns JL, Campbell M, Sundar H. NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022. J Natl Compr Canc Netw. 2022 Apr;20(4):322-334. doi: 10.6004/jnccn.2022.0021. PMID: 35390768.
  • Ross RB, Rabinovitch RA. Radiation recall after COVID-19 infection. Lancet Oncol. 2022 Apr;23(4):e197. doi: 10.1016/S1470-2045(22)00038-9. PMID: 35358468; PMCID: PMC8959476.
  • Esteva A, Feng J, van der Wal D, Huang SC, Simko JP, DeVries S, Chen E, Schaeffer EM, Morgan TM, Sun Y, Ghorbani A, Naik N, Nathawani D, Socher R, Michalski JM, Roach M 3rd, Pisansky TM, Monson JM, Naz F, Wallace J, Ferguson MJ, Bahary JP, Zou J, Lungren M, Yeung S, Ross AE; NRG Prostate Cancer AI Consortium; Sandler HM, Tran PT, Spratt DE, Pugh S, Feng FY, Mohamad O. Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials. NPJ Digit Med. 2022 Jun 8;5(1):71. doi: 10.1038/s41746-022-00613-w. Erratum in: NPJ Digit Med. 2023 Feb 22;6(1):27. PMID: 35676445; PMCID: PMC9177850.
  • Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Andreadis B, Bartlett NL, Budde LE, Caimi PF, Chang JE, Christian B, DeVos S, Dholaria B, Fayad LE, Habermann TM, Hamid MS, Hernandez-Ilizaliturri F, Hu B, Kaminski MS, Karimi Y, Kelsey CR, King R, Krivacic S, LaCasce AS, Lim M, Messmer M, Narkhede M, Rabinovitch R, Ramakrishnan P, Reid E, Roberts KB, Saeed H, Smith SD, Svoboda J, Swinnen LJ, Tuscano J, Vose JM, Dwyer MA, Sundar H. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023. J Natl Compr Canc Netw. 2023 Nov;21(11):1118-1131. PubMed PMID: 37935098
  • Nguyen PL, Huang HR, Spratt DE, Davicioni E, Sandler HM, Shipley WU, Efstathiou JA, Simko JP, Pollack A, Dicker AP, Roach M, Rosenthal SA, Zeitzer KL, Mendez LC, Hartford AC, Hall WA, Desai AB, Rabinovitch RA, Peters CA, Rodgers JP, Tran P, Feng FY. Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials. Int J Radiat Oncol Biol Phys. 2023 Jul 1;116(3):521-529. PubMed PMID: 36596347
  • Vicini FA, Mann GB, Shah C, Weinmann S, Leo MC, Whitworth P, Rabinovitch R, Torres MA, Margenthaler JA, Dabbs D, Savala J, Shivers SC, Mittal K, Wärnberg F, Bremer T. A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023 Jan 1;115(1):93-102. PubMed PMID: 36115740

Professional Memberships

  • ASTRO - American Society of Therapeutic Radiology and Oncology, Member
  • RTOG - Radiation Therapy Oncology Group, Chair, Quality Control Committee
  • RTOG - Radiation Therapy Oncology Group, Breast Working Group Member
  • American College of Radiology, Member
  • American Society of Hematology and Oncology, Member
  • American Society of Clinical Oncology, Member
  • NCI Breast Steering Committee, Breast Oncology Local Disease Task Force, Member

Practice Locations

University of Colorado Cancer Center - Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045
720-848-0300

UCHealth Radiation Oncology - Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045
720-848-0100

UCHealth Highlands Ranch Hospital
1500 Park Central Drive
Highlands Ranch, CO 80129
720-516-1000

Hospital Affiliation
  • University of Colorado Hospital

Center Affiliations

Specialty Information

Specialties
  • Radiation Oncology, Board Certification (1994)
Conditions & Treatments
  • Cancers - Breast Cancer
  • Cancers - Lymphoma
  • Cancers - Radiation Therapy
  • Cancers
Clinical Interests
My clinical and research interests relate to the treatment of Breast Cancer, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, and Total Body Irradiation for cell transplantation. I have extensive experience with accelerated whole breast radiotherapy and partial breast radiation. Whenever an option, I makes sure my patients are aware of clinical trial opportunities. I am dedicated to providing attentive, compassionate and personalized treatment to every patient.

Care Philosophy
I am dedicated to warm, compassionate and individualized care for each patient. Cancer care can be very complicated, and it is important to me that my patients are informed and educated partners in whatever treatment they chose to receive. I offer patient-tailored treatment based upon the latest research experience in the field.